Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts.
about
Liposomal delivery systems for intestinal lymphatic drug transportPreparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.Is decabromodiphenyl ether (BDE-209) a developmental neurotoxicant?Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.Carvedilol nano lipid carriers: formulation, characterization and in-vivo evaluation.Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs.Nanostructured lipid carriers: versatile oral delivery vehicle.Nanostructured lipid carriers system: recent advances in drug delivery.Formulation approaches in mitigating toxicity of orally administrated drugs.Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals.Adjuvants and lymphoma risk as part of the ASIA spectrum.Role of microemuslsions in advanced drug delivery.Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs.Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.Vaults engineered for hydrophobic drug delivery.Preparation and In-vitro Evaluation of Rifampin-loaded Mesoporous Silica Nanoaggregates by an Experimental DesignPreparation and bioavailability assessment of SMEDDS containing valsartan.A comparative evaluation of mono-, di- and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development.Formulation design, in vitro characterizations and anti-malarial investigations of artemether and lumefantrine-entrapped solid lipid microparticles.Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.Preparation and characterization of rifampin loaded mesoporous silica nanoparticles as a potential system for pulmonary drug delivery.Studies on dissolution enhancement of prednisolone, a poorly water-soluble drug by solid dispersion techniquePhysicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and d-mannitol.Formulation Development and Characterization of Meclizine Hydrochloride Sublimated Fast Dissolving TabletsDesign of self-microemulsifying drug delivery systems using a high-throughput formulation screening system.Studying the effect of lipid chain length on the precipitation of a poorly water soluble drug from self-emulsifying drug delivery system on dispersion into aqueous medium.High-throughput formulation screening system for self-microemulsifying drug delivery.Mixed-micellar proliposomal systems for enhanced oral delivery of progesterone.Formulation and statistical optimization of self-microemulsifying drug delivery system of eprosartan mesylate for improvement of oral bioavailability.Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks.Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration.Preparation, characterization and in vitro evaluation of microemulsion of raloxifene hydrochloride.Production and characterization of testosterone undecanoate-loaded NLC for oral bioavailability enhancement.Development, characterization, and pharmacodynamic evaluation of hydrochlorothiazide loaded self-nanoemulsifying drug delivery systems
P2860
Q28067324-40DAA900-22BA-4154-8006-4F35374DB10CQ33893117-CDC7AE28-5C09-4431-90F3-EE5E098C8B33Q34156424-8C7DB314-4341-4ADE-8F90-EF765CEEAB99Q34562249-4CE79F34-E3AC-4BB0-8A23-E3894E8EFA1AQ34733880-E3A30746-DE4A-4BCD-9074-1E3C27FEBE26Q35957617-3323FD19-1DB3-410D-A1A5-893FF292496FQ36349701-17C4A4FE-52D2-485D-B9D8-DF0B66E36314Q37474497-D9166B1D-B0E5-486A-93FD-BF47ABC922AFQ38038902-0528A7D8-87B0-4CE5-9178-571548F2114BQ38073886-93EB5CBA-4F67-4537-9060-AE946AB513FCQ38199540-F4D5936F-1770-45EA-BDBC-9349A88BD887Q38242752-8D932E29-7121-4C51-8A4D-9A328234404AQ38316047-26CD3AD9-7FB1-4B2C-8CA0-F6860D4041B1Q38364835-334F0BE2-2713-480A-BEF1-646BC020ADBCQ38406190-428D8DE4-5C84-4F9D-837B-E402FF242D85Q38729314-1A02159E-A237-419B-B071-012EE433C2B6Q39555815-BC87D70B-A984-40E2-BA52-BA67C0548A75Q39785447-3238AE6E-89CE-4A3D-8CA0-82EC96343ED7Q39922643-D6BA20B0-1692-42FD-AD9E-BE928A70D621Q40004853-5BDEE832-0B62-4268-91DB-AA8C2086379CQ40707426-FDB85D4C-8E10-43FD-8D7D-936BC63F9EA9Q41809141-5BC1F47E-214A-48D6-BBAF-FBCEA154775CQ42027067-C95E21AE-9BD7-48AD-8032-6334032C1DB8Q42102623-C066C913-0723-4DEE-9734-C615DBFCA817Q42234481-9FBC21E1-E342-4FA9-A705-E9CC6F19F0CBQ42737940-24C273A4-8485-44B3-8BFA-2BCF400BF977Q43109673-AF159725-A4D5-411A-984C-0241E32D9463Q44777406-94ED3687-D205-4A1E-A212-53FF1A1D653BQ45974657-11FF0B8A-3012-4EE9-B704-DCA5E102E2D3Q46400615-DDF1A038-771B-46ED-927A-35518BED5EEEQ48139510-41CF97F3-8E6E-4B82-B817-2E2FAC8D2F37Q48273811-9632239A-E227-449F-8E6E-E81F16EBAB39Q48376807-BE213828-1FEF-4F02-BFD9-0141939D4BA1Q50881321-02BBCAD3-DAF1-481A-AEED-C73E15638CF2Q52899992-E9AB3B8F-8508-44E9-9B11-ACBD518A9868Q59075261-464076E1-3F56-4D46-B03A-B65D38EBDC41
P2860
Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts.
@ast
Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts.
@en
type
label
Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts.
@ast
Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts.
@en
prefLabel
Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts.
@ast
Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts.
@en
P1476
Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts.
@en
P2093
Charman WN
P304
P356
10.1002/1520-6017(200008)89:8<967::AID-JPS1>3.0.CO;2-R
P407
P577
2000-08-01T00:00:00Z